Ledger.Open graph →
SEC Form D · filed September 12, 2022

Reactive Biosciences Inc

Offering
$40.0M
Sold
$23.5M
Exemption
Rule 506(b)
Industry
Other
Location
DURHAM, NC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Julie Grant · Durham, NCExec · DirectorPeter Farina · Durham, NCDirectorEsther Van Den Boom · Durham, NCExecMarlon Nichols · Los Angeles, CAExec · DirectorMichael Greeley · Boston, MAExecMichael Palank · Los Angeles, CADirectorJune Hee Han · Union, NJExecTimothy Van Den Broek · Moscow, IDExec · DirectorAndrew Crapuchettes · Moscow, IDDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗